- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Celebrating Pride Month With Lancaster Pride
For June and Pride Month, we are bringing you our newest limited-edition podcast series. In this first episode, we speak with Lancaster, Pennsylvania, native and president of Lancaster Pride, Tiffany Shirley.
This discussion touches on, among other important issues, access to health care and health care equity, which have been hot-button topics of discussion as of late | Image Credit: Lancaster Pride
Welcome to another episode of Managed Care Cast and the first podcast in our series to celebrate Pride Month in 2024. In this episode, we speak with Lancaster, Pennsylvania, native and president of Lancaster Pride, Tiffany Shirley. We learn about the history of Lancaster Pride, how Shirley shaped her identity as a member of the LGBTQ+ community, the origin of their slogan "Hate Has No Home Here," and policy priorities in an election year to foster a more inclusive and understanding environment for all.
The discussion also touches upon the importance of access to health care and health care equity that have been hot-button topics of discussion as of late, particularly in this election year. Shirley is an ardent advocate for legislation that emphasizes insurance coverage without discriminatory exclusions, affordable mental health care, increasing funding for mental health services tailored for the LGBTQ+ community, and antidiscrimination protections in health care.
Listen above or through one of these podcast services:
Health Equity & Access Weekly Roundup: January 11, 2025
January 11th 2025ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
